Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

DexCom (NASDAQ:DXCM) Gets a Barclays Upgrade and a Run of Higher Price Targets

● Market data consensus target is $91.96, implying about 9.3% upside.

Nitish Kishor | 12 October 2026

Elevance Health (NYSE:ELV) Gains Ground With No Sell Ratings From Analysts

● Market data consensus target is $441.48, implying about 7.0 per cent upside.

Nitish Kishor | 12 October 2026

Edwards Lifesciences (NYSE:EW) Trades Below Almost Every Published Analyst Target

● Market data consensus target is $100.27, implying about 17.6% upside.

Nitish Kishor | 12 October 2026

Gilead Sciences (NASDAQ:GILD) Trades Below Its Analyst Consensus Target

● Market data consensus target is $159.26, implying about 5.35% upside.

Nitish Kishor | 12 October 2026

What Is the Latest Price Target for CVS Health (NYSE:CVS) in the S&P 500?

● CVS closed at $86.15 on 9 October 2026, and the second data set's $115.76 mean target implies upside of about 34%.

Nitish Kishor | 12 October 2026

Quest Diagnostics (NYSE:DGX) Price Target: Why Do Consensus Figures Not Line Up?

● DGX closed at $231.07 on 9 October 2026, below every recent named broker target, which sit between $245 and $260.

Nitish Kishor | 12 October 2026

What Is the Price Target for Danaher (NYSE:DHR) in the S&P 500?

● DHR closed at $220.15 on 9 October 2026, and the $235.23 consensus target implies upside of about 6.9 per cent.

Nitish Kishor | 12 October 2026

Cigna Group (NYSE:CI) Price Target: How Do Analysts See the Health Insurer?

● CI closed at $282.24 on 9 October 2026, and the $338.24 consensus target implies upside of about 19.8%.

Nitish Kishor | 12 October 2026

Cooper Companies (NASDAQ:COO) Price Target: What Do Analysts Expect After the September Cuts?

● COO closed at $54.37 on 9 October 2026, and the second data set's $65.80 mean target implies upside of about 21.0%.

Nitish Kishor | 12 October 2026

What Are Wall Street Analysts Forecasting for Cencora (NYSE:COR) in the S&P 500?

● COR closed at $323.59 on 9 October 2026, and the $372.07 consensus target implies upside of about 15.0 per cent.

Nitish Kishor | 12 October 2026
Support

Hi! How can we help you today?

Loading…